Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's Humira biosimilar clears Phase III and joins a crowd of contenders
Amgen's Humira biosimilar clears Phase III and joins a crowd of contenders
Amgen's Humira biosimilar clears Phase III and joins a crowd of contenders
Submitted by
admin
on November 11, 2015 - 10:04am
Source:
Fierce Biotech
News Tags:
Amgen
Humira
biosimilars
rheumatoid arthritis
Headline:
Amgen's Humira biosimilar clears Phase III and joins a crowd of contenders
Do Not Allow Advertisers to Use My Personal information
